The Latest Cardiac and Vascular News
Canadian company drives at-home cardiac monitoring nationwide during pandemic QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc., a California-based medical device company, introduces the Reflow™ Spex™ LP (Low Profile) 0.014 and 0.018-inch reinforced support catheters. The new Spex LP is engineered to provide the lowest profile tip for accessing and crossing the tightest and most complex lesions with a supportive system. It also […]
Results Validate Findings of Initial Study; End Points Achieved with No Intraoperative Adverse Events Management Presenting at Needham Growth Conference Today at 2:00pm ET HINGHAM, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — The continued progression of Microbot Medical Inc.’s (Nasdaq: MBOT) LIBERTY™ Robotic System was further demonstrated as the Company announced […]
Latest Approval Joins a Growing List of Countries for Commercial Sales in 2021 JUPITER, Fla., Jan. 14, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that its flagship product DuraGraft® is […]
THE WOODLANDS, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has received U.S. Food and Drug Administration (FDA) regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support a new drug application (NDA) submission for an indication to […]
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed […]
CRANBURY, N.J.–(BUSINESS WIRE)–HCPLive® and The American Journal of Managed Care® (AJMC®) are excited to announce the addition of The American Society for Preventive Cardiology (ASPC) to their Strategic Alliance Partnership (SAP) programs. “We’re very honored to be able to join forces with ASPC to help promote the prevention of cardiovascular disease,” said Mike Hennessy Jr., […]
International Trial to Compare Bioadaptor, a Novel Coronary Artery Implant Designed to Adapt to Vessel Physiology, with Traditional Drug Eluting Stents MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that the first patient has been treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX™ […]
– Fourth-quarter 2020 U.S. net product revenue estimated between $8.0 and $8.5 million – – Range represents over 140 percent sequential growth for NEXLETOL® (bempedoic acid) tablets and NEXLIZET® (bempedoic acid and ezetimibe) tablets – – Company provides full-year 2021 operating expense guidance – – In-licensed oral PCSK9 inhibitor program furthers ESPERION […]
CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. Preliminary Fourth Quarter and Full […]
